These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 1641712)

  • 1. Screening for syphilis and neurosyphilis in acute psychiatric admissions.
    Roberts MC; Emsley RA; Jordaan GP
    S Afr Med J; 1992 Jul; 82(1):16-8. PubMed ID: 1641712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of cerebrospinal fluid tests for neurosyphilis.
    Russouw HG; Roberts MC; Emsley RA; Joubert JJ
    S Afr Med J; 1994 Oct; 84(10):682-4. PubMed ID: 7839257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of cerebrospinal fluid tests for neurosyphilis.
    Davis LE; Schmitt JW
    Ann Neurol; 1989 Jan; 25(1):50-5. PubMed ID: 2643918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treponemal serum tests performed on cerebrospinal fluid for diagnosis of neurosyphilis.
    Guarner J; Jost H; Pillay A; Sun Y; Cox D; Notenboom R; Workowski K
    Am J Clin Pathol; 2015 Apr; 143(4):479-84. PubMed ID: 25779998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and therapy of neurosyphilis in patients who are negative for human immunodeficiency virus].
    Pavlović DM; Milović AM
    Srp Arh Celok Lek; 1999; 127(7-8):236-40. PubMed ID: 10624396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for the diagnosis of neurosyphilis in cerebrospinal fluid: relationships with intrathecal immunoglobulin synthesis and blood-cerebrospinal fluid barrier dysfunction.
    Levchik N; Ponomareva M; Surganova V; Zilberberg N; Kungurov N
    Sex Transm Dis; 2013 Dec; 40(12):917-22. PubMed ID: 24220351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosyphilis is unlikely in patients with late latent syphilis and a negative blood VDRL-test.
    Wöhrl S; Geusau A
    Acta Derm Venereol; 2006; 86(4):335-9. PubMed ID: 16874420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serologic screening for neurosyphilis].
    Bekkelund SI; Grønli O; Johnsen SH
    Tidsskr Nor Laegeforen; 2001 Mar; 121(7):786-8. PubMed ID: 11301698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological false-positive venereal disease research laboratory test in cerebrospinal fluid in the diagnosis of neurosyphilis - a case-control study.
    Zheng S; Lin RJ; Chan YH; Ngan CCL
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):474-481. PubMed ID: 29117430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis.
    Marra CM; Tantalo LC; Maxwell CL; Ho EL; Sahi SK; Jones T
    Sex Transm Dis; 2012 Jun; 39(6):453-7. PubMed ID: 22592831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests.
    Castro R; Prieto ES; da Luz Martins Pereira F
    J Clin Lab Anal; 2008; 22(4):257-61. PubMed ID: 18623120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of laboratory findings for the diagnosis of neurosyphilis.
    Luger AF; Schmidt BL; Kaulich M
    Int J STD AIDS; 2000 Apr; 11(4):224-34. PubMed ID: 10772085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care treponemal tests for neurosyphilis diagnosis.
    Ho EL; Tantalo LC; Jones T; Sahi SK; Marra CM
    Sex Transm Dis; 2015 Jan; 42(1):48-52. PubMed ID: 25504301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of neurosyphilis by examination of the cerebrospinal fluid.
    Luger A; Schmidt BL; Steyrer K; Schonwald E
    Br J Vener Dis; 1981 Aug; 57(4):232-7. PubMed ID: 7023601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate use of the cerebrospinal fluid Venereal Disease Research Laboratory (VDRL) test to exclude neurosyphilis.
    Dans PE; Cafferty L; Otter SE; Johnson RJ
    Ann Intern Med; 1986 Jan; 104(1):86-9. PubMed ID: 3510057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of serological criteria for early syphilis treatment efficacy: progression to neurosyphilis despite therapy.
    Zhou P; Gu X; Lu H; Guan Z; Qian Y
    Sex Transm Infect; 2012 Aug; 88(5):342-5. PubMed ID: 22363023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Well Do Neurologic Symptoms Identify Individuals With Neurosyphilis?
    Davis AP; Stern J; Tantalo L; Sahi S; Holte S; Dunaway S; Marra CM
    Clin Infect Dis; 2018 Jan; 66(3):363-367. PubMed ID: 29020214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Screening and Prevalence of Neurosyphilis in Stroke Population.
    Targa Martins R; Castilhos RM; Silva da Silva P; Costa LS
    Cerebrovasc Dis; 2020; 49(3):301-306. PubMed ID: 32570248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic evaluation of syphilis during pregnancy.
    Jones JE; Harris RE
    Obstet Gynecol; 1979 Nov; 54(5):611-4. PubMed ID: 388268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.
    Marra CM; Maxwell CL; Smith SL; Lukehart SA; Rompalo AM; Eaton M; Stoner BP; Augenbraun M; Barker DE; Corbett JJ; Zajackowski M; Raines C; Nerad J; Kee R; Barnett SH
    J Infect Dis; 2004 Feb; 189(3):369-76. PubMed ID: 14745693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.